triple-hormone-receptor agonist retatrutide for obesity investigational drug triple hormone receptor First Retatrutide phase 3 data, a Triumph of Science! From to Metabolic retatrutide phase 2 trial obesity
Pay in 4 interest-free payments of $7.18 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
























